tirzepatide no longer in shortage FDA declares Mounjaro, Zepbound over Mounjaro and Zepbound no longer

Serious adverse events were slightly higher with Zepbound (4.8%) than Wegovy (3.5%), but discontinuation rates due to side effects were identical (6 patients in each group)

If your goal is modest, phentermine can get you there without the cost, injections, or months-long titration of tirzepatide

For example, someone who reached goal at 15 mg might discover they maintain well at 12.5 mg

By combining modern medical treatments with traditional wellness practices, we strive to help you lead a balanced and healthy life.

Category: FDA Labels and Prescribing Information Mounjaro (tirzepatide) US FDA prescribing information